chr4-113365051-T-A

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BS1BS2

The NM_001148.6(ANK2):​c.10901T>A​(p.Val3634Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00209 in 1,613,852 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0021 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0021 ( 22 hom. )

Consequence

ANK2
NM_001148.6 missense

Scores

1
6
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:8O:1

Conservation

PhyloP100: 3.50
Variant links:
Genes affected
ANK2 (HGNC:493): (ankyrin 2) This gene encodes a member of the ankyrin family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton. Ankyrins play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. The protein encoded by this gene is required for targeting and stability of Na/Ca exchanger 1 in cardiomyocytes. Mutations in this gene cause long QT syndrome 4 and cardiac arrhythmia syndrome. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Dec 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), ANK2. . Gene score misZ 1.9641 (greater than the threshold 3.09). Trascript score misZ 4.2513 (greater than threshold 3.09). GenCC has associacion of gene with heart conduction disease, Brugada syndrome, long QT syndrome, complex neurodevelopmental disorder, cardiac arrhythmia, ankyrin-B-related, catecholaminergic polymorphic ventricular tachycardia.
BP4
Computational evidence support a benign effect (MetaRNN=0.01469788).
BP6
Variant 4-113365051-T-A is Benign according to our data. Variant chr4-113365051-T-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 67599.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=6, Benign=1, not_provided=1, Uncertain_significance=2}. Variant chr4-113365051-T-A is described in Lovd as [Benign]. Variant chr4-113365051-T-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00206 (314/152274) while in subpopulation AMR AF= 0.00464 (71/15290). AF 95% confidence interval is 0.00378. There are 1 homozygotes in gnomad4. There are 159 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 314 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ANK2NM_001148.6 linkuse as main transcriptc.10901T>A p.Val3634Asp missense_variant 41/46 ENST00000357077.9 NP_001139.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ANK2ENST00000357077.9 linkuse as main transcriptc.10901T>A p.Val3634Asp missense_variant 41/461 NM_001148.6 ENSP00000349588 A2Q01484-4

Frequencies

GnomAD3 genomes
AF:
0.00205
AC:
312
AN:
152156
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000290
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00465
Gnomad ASJ
AF:
0.00375
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.00151
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00266
Gnomad OTH
AF:
0.00479
GnomAD3 exomes
AF:
0.00245
AC:
615
AN:
251264
Hom.:
4
AF XY:
0.00256
AC XY:
348
AN XY:
135796
show subpopulations
Gnomad AFR exome
AF:
0.000554
Gnomad AMR exome
AF:
0.00202
Gnomad ASJ exome
AF:
0.00347
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000686
Gnomad FIN exome
AF:
0.00125
Gnomad NFE exome
AF:
0.00374
Gnomad OTH exome
AF:
0.00457
GnomAD4 exome
AF:
0.00209
AC:
3057
AN:
1461578
Hom.:
22
Cov.:
32
AF XY:
0.00221
AC XY:
1610
AN XY:
727094
show subpopulations
Gnomad4 AFR exome
AF:
0.000807
Gnomad4 AMR exome
AF:
0.00165
Gnomad4 ASJ exome
AF:
0.00432
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000626
Gnomad4 FIN exome
AF:
0.00142
Gnomad4 NFE exome
AF:
0.00215
Gnomad4 OTH exome
AF:
0.00306
GnomAD4 genome
AF:
0.00206
AC:
314
AN:
152274
Hom.:
1
Cov.:
32
AF XY:
0.00214
AC XY:
159
AN XY:
74468
show subpopulations
Gnomad4 AFR
AF:
0.000313
Gnomad4 AMR
AF:
0.00464
Gnomad4 ASJ
AF:
0.00375
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.000829
Gnomad4 FIN
AF:
0.00151
Gnomad4 NFE
AF:
0.00266
Gnomad4 OTH
AF:
0.00474
Alfa
AF:
0.00266
Hom.:
1
Bravo
AF:
0.00196
TwinsUK
AF:
0.00243
AC:
9
ALSPAC
AF:
0.00363
AC:
14
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00314
AC:
27
ExAC
AF:
0.00273
AC:
332
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:8Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingGeneDxJan 22, 2021In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31920912, 32164423, 24025405, 17242276, 27884173, 23631430, 23174487) -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024ANK2: PM5, BP4, BS2 -
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMar 27, 2017- -
Cardiac arrhythmia Benign:1Other:1
not provided, no classification providedliterature onlyCardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust-This variant has been reported as associated with Cardiac arrhythmia in the following publications (PMID:17242276). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -
Likely benign, criteria provided, single submitterresearchBiesecker Lab/Clinical Genomics Section, National Institutes of HealthJun 24, 2013- -
Conduction disorder of the heart Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingMolecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart InstituteNov 18, 2019- -
Cardiac arrhythmia, ankyrin-B-related Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
ANK2-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMay 30, 2019This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Familial dilated cardiomyopathy and peripheral neuropathy Benign:1
Benign, criteria provided, single submitterclinical testingCenter for Advanced Laboratory Medicine, UC San Diego Health, University of California San DiegoJun 03, 2019- -
Long QT syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 22, 2024- -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 14, 2018This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.61
BayesDel_addAF
Benign
-0.10
T
BayesDel_noAF
Uncertain
0.080
CADD
Uncertain
23
DANN
Benign
0.97
DEOGEN2
Uncertain
0.46
.;.;T;T;D;.;D
Eigen
Benign
-0.14
Eigen_PC
Benign
0.022
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.89
D;D;D;D;D;D;D
M_CAP
Uncertain
0.22
D
MetaRNN
Benign
0.015
T;T;T;T;T;T;T
MetaSVM
Benign
-0.50
T
MutationAssessor
Benign
1.2
.;.;L;.;.;.;.
MutationTaster
Benign
1.0
D;D;D;N;N;N
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-1.8
N;N;N;N;N;D;D
REVEL
Uncertain
0.61
Sift
Benign
0.36
T;T;T;D;T;T;D
Sift4G
Benign
0.28
T;T;D;D;T;T;T
Polyphen
0.039
B;B;.;.;B;.;.
Vest4
0.69
MVP
0.98
MPC
0.16
ClinPred
0.028
T
GERP RS
4.3
Varity_R
0.14
gMVP
0.72

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs66785829; hg19: chr4-114286207; API